All the trading advice you’ve ever received boils down to this

All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.

Drop everything and learn about the Income Calendar now.

PMVP Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.60%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $222,931.26

PMV Pharmaceuticals Insider Trading History Chart

PMV Pharmaceuticals Share Price & Price History

^$2.31

▲ +0.01 (0.43%)

As of 12/8/2023 09:57 PM ET

Days: 30 | 90 | 365

All the trading advice you’ve ever received boils down to this

From DTI Trader | Ad

Drop everything and learn about the Income Calendar now.

PMV Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/22/2023	Orbimed Advisors Llc	Major Shareholder	Sell	87,786	$2.23	$195,762.78
9/15/2023	Deepika Jalota	Insider	Sell	4,104	$6.62	$27,168.48	29,946
5/26/2022	Orbimed Advisors Llc	Major Shareholder	Sell	26,253	$15.93	$418,210.29	87,786
3/31/2022	Orbimed Advisors Llc	Major Shareholder	Sell	34,500	$21.17	$730,365.00
3/29/2022	Orbimed Advisors Llc	Major Shareholder	Sell	365,000	$21.52	$7,854,800.00
10/6/2021	Thilo Schroeder	Director	Sell	800	$30.15	$24,120.00
10/4/2021	Thilo Schroeder	Director	Sell	100	$30.08	$3,008.00
10/1/2021	Thilo Schroeder	Director	Sell	11,541	$30.10	$347,384.10
9/29/2021	Thilo Schroeder	Director	Sell	5,708	$30.04	$171,468.32
9/27/2021	Thilo Schroeder	Director	Sell	1,753	$30.11	$52,782.83
9/22/2021	Arnold J. Levine	Director	Sell	3,500	$30.00	$105,000.00
9/17/2021	Thilo Schroeder	Director	Sell	711	$30.03	$21,351.33
9/13/2021	Thilo Schroeder	Director	Sell	13,272	$30.20	$400,814.40
9/9/2021	Thilo Schroeder	Director	Sell	14,329	$30.31	$434,311.99
9/7/2021	Leila Alland	Insider	Sell	3,900	$30.25	$117,975.00
9/1/2021	Thilo Schroeder	Director	Sell	21,986	$30.38	$667,934.68
8/30/2021	Thilo Schroeder	Director	Sell	13,233	$30.05	$397,651.65
8/27/2021	Thilo Schroeder	Director	Sell	24,442	$30.52	$745,969.84
8/25/2021	Thilo Schroeder	Director	Sell	13,526	$31.01	$419,441.26
8/23/2021	Arnold J. Levine	Director	Sell	3,500	$29.50	$103,250.00	413,342
8/18/2021	Thilo Schroeder	Director	Sell	26,864	$33.34	$895,645.76
8/16/2021	Thilo Schroeder	Director	Sell	22,183	$33.89	$751,781.87
8/13/2021	Thilo Schroeder	Director	Sell	27,286	$34.24	$934,272.64
8/11/2021	Thilo Schroeder	Director	Sell	34,439	$34.04	$1,172,303.56
8/9/2021	Leila Alland	Insider	Sell	4,471	$34.04	$152,192.84
8/9/2021	Thilo Schroeder	Director	Sell	22,182	$35.53	$788,126.46
8/6/2021	Thilo Schroeder	Director	Sell	19,900	$36.61	$728,539.00
8/4/2021	Thilo Schroeder	Director	Sell	52,860	$35.85	$1,895,031.00
8/3/2021	Winston Kung	CFO	Sell	4,500	$33.82	$152,190.00	6,100
8/2/2021	Thilo Schroeder	Director	Sell	13,031	$34.74	$452,696.94
7/28/2021	Thilo Schroeder	Director	Sell	8,724	$35.76	$311,970.24
7/26/2021	Thilo Schroeder	Director	Sell	4,839	$35.73	$172,897.47
7/22/2021	Thilo Schroeder	Director	Sell	200	$35.61	$7,122.00
7/20/2021	Arnold J. Levine	Director	Sell	3,500	$35.12	$122,920.00
7/20/2021	David Henry Mack	CEO	Sell	1,029	$35.53	$36,560.37
7/8/2021	Winston Kung	CFO	Sell	4,500	$33.75	$151,875.00
7/7/2021	Leila Alland	Insider	Sell	4,000	$32.30	$129,200.00
6/28/2021	David Henry Mack	CEO	Sell	204	$35.53	$7,248.12	12,674
6/21/2021	Arnold J. Levine	Director	Sell	3,500	$33.25	$116,375.00	420,453
6/14/2021	Euclidean Capital Llc	Major Shareholder	Sell	44,419	$34.11	$1,515,132.09
6/11/2021	Euclidean Capital Llc	Major Shareholder	Sell	21,977	$33.80	$742,822.60
6/9/2021	Euclidean Capital Llc	Major Shareholder	Sell	39,638	$33.64	$1,333,422.32
6/7/2021	Euclidean Capital Llc	Major Shareholder	Sell	30,721	$33.62	$1,032,840.02
6/7/2021	Leila Alland	Insider	Sell	4,000	$33.60	$134,400.00	4,000
6/4/2021	Winston Kung	CFO	Sell	4,500	$33.75	$151,875.00	6,100
6/1/2021	Richard A. Heyman	Director	Sell	3,900	$32.55	$126,945.00
5/28/2021	Thilo Schroeder	Director	Sell	5,100	$35.80	$182,580.00
5/26/2021	Thilo Schroeder	Director	Sell	7,487	$35.66	$266,986.42
5/24/2021	Thilo Schroeder	Director	Sell	22,095	$36.03	$796,082.85
5/21/2021	David Henry Mack	CEO	Sell	6,207	$35.71	$221,651.97	10,263
5/20/2021	Arnold J. Levine	Director	Sell	3,500	$34.51	$120,785.00	426,803
5/10/2021	Thilo Schroeder	Director	Sell	1,787	$35.67	$63,742.29
5/7/2021	Leila Alland	Insider	Sell	4,000	$34.83	$139,320.00	4,000
5/5/2021	Thilo Schroeder	Director	Sell	600	$35.64	$21,384.00
5/3/2021	Winston Kung	CFO	Sell	4,500	$33.75	$151,875.00	6,100
4/12/2021	Thilo Schroeder	Director	Sell	3,903	$31.41	$122,593.23
4/8/2021	Thilo Schroeder	Director	Sell	136,436	$34.31	$4,681,119.16
4/7/2021	Leila Alland	Insider	Sell	4,000	$33.86	$135,440.00	4,000
4/5/2021	Thilo Schroeder	Director	Sell	48,193	$33.81	$1,629,405.33
3/31/2021	Thilo Schroeder	Director	Sell	33,626	$32.52	$1,093,517.52
3/29/2021	Thilo Schroeder	Director	Sell	2,174	$32.15	$69,894.10
3/26/2021	Thilo Schroeder	Director	Sell	35,268	$33.44	$1,179,361.92
3/24/2021	Thilo Schroeder	Director	Sell	34,881	$36.50	$1,273,156.50

Lithium Discovery So BIG You Can't Miss it, Even From Space

From Financial Alphas | Ad

With the green energy transition well underway, lithium demand is rapidly outpacing projected supply. While companies frantically search for new sources of this critical metal, one small company is sitting on a massive claim in North America - So big in fact that it can clearly be seen from space!

Free Investor Report Reveals Ambitious Plan To Mee

SEC Filings (Institutional Ownership Changes) for PMV Pharmaceuticals (NASDAQ:PMVP)

Institutional Buying and Selling by Quarter

PMV Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/6/2023	Citigroup Inc.	365,564	$2.25M	0.0%	+468.4%	0.715%
12/1/2023	Euclidean Capital LLC	2,627,643	$16.13M	3.5%	+3.2%	5.136%
12/1/2023	Wellington Management Group LLP	542,883	$3.33M	0.0%	-4.1%	1.061%
11/30/2023	American Century Companies Inc.	28,811	$0.18M	0.0%	+39.4%	0.056%
11/15/2023	GSA Capital Partners LLP	13,045	$80K	0.0%	-88.6%	0.025%
11/15/2023	RTW Investments LP	2,375,785	$14.59M	0.3%	-21.6%	4.644%
11/15/2023	Sectoral Asset Management Inc.	303,824	$1.87M	0.4%	-8.6%	0.594%
11/15/2023	JPMorgan Chase & Co.	4,033,721	$24.77M	0.0%	-1.0%	7.885%
11/15/2023	Alkeon Capital Management LLC	2,347,414	$14.41M	0.0%	+58.6%	4.588%
11/15/2023	AQR Capital Management LLC	14,611	$90K	0.0%	-38.3%	0.029%
11/14/2023	Schonfeld Strategic Advisors LLC	71,295	$0.44M	0.0%	N/A	0.139%
11/14/2023	Qube Research & Technologies Ltd	63,976	$0.39M	0.0%	-42.3%	0.125%
11/14/2023	Trexquant Investment LP	68,202	$0.42M	0.0%	N/A	0.133%
11/14/2023	PEAK6 Investments LLC	32,500	$0.20M	0.0%	N/A	0.064%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	169,699	$1.04M	0.0%	+3.5%	0.332%
11/13/2023	Algert Global LLC	27,790	$0.17M	0.0%	N/A	0.054%
11/13/2023	Northern Trust Corp	339,729	$2.09M	0.0%	+5.9%	0.664%
11/13/2023	Federated Hermes Inc.	783,539	$4.81M	0.0%	-6.8%	1.532%
11/13/2023	Hsbc Holdings PLC	30,679	$0.18M	0.0%	-21.4%	0.060%
11/9/2023	Citigroup Inc.	365,564	$2.25M	0.0%	+468.4%	0.754%
11/9/2023	UBS Group AG	143,681	$0.88M	0.0%	+47.0%	0.296%
11/8/2023	Charles Schwab Investment Management Inc.	269,597	$1.66M	0.0%	+3.8%	0.556%
11/8/2023	New York Life Investment Management LLC	74,525	$0.46M	0.0%	-13.7%	0.154%
11/7/2023	Barclays PLC	471,012	$2.89M	0.0%	+96.0%	0.972%
11/6/2023	Assenagon Asset Management S.A.	258,538	$1.59M	0.0%	-38.6%	0.534%
11/6/2023	Los Angeles Capital Management LLC	44,832	$0.28M	0.0%	-28.3%	0.093%
11/2/2023	Principal Financial Group Inc.	919,142	$5.64M	0.0%	-0.8%	1.897%
10/11/2023	Vontobel Holding Ltd.	303,824	$1.87M	0.0%	-8.6%	0.627%
8/21/2023	California State Teachers Retirement System	12,829	$80K	0.0%	-59.5%	0.026%
8/15/2023	Alliancebernstein L.P.	49,090	$0.31M	0.0%	+5.6%	0.101%
8/15/2023	Wells Fargo & Company MN	14,649	$92K	0.0%	+124.7%	0.030%
8/15/2023	Fishman Jay A Ltd. MI	30,000	$0.19M	0.0%	+20.0%	0.062%
8/15/2023	Walleye Capital LLC	11,471	$72K	0.0%	-79.5%	0.024%
8/15/2023	Woodline Partners LP	733,735	$4.59M	0.1%	+317.2%	1.514%
8/15/2023	XTX Topco Ltd	27,225	$0.17M	0.0%	N/A	0.056%
8/15/2023	Goldman Sachs Group Inc.	639,045	$4M	0.0%	-2.2%	1.319%
8/15/2023	Royal Bank of Canada	4,024	$25K	0.0%	+94.7%	0.008%
8/14/2023	PDT Partners LLC	49,713	$0.31M	0.0%	-43.7%	0.103%
8/14/2023	ArrowMark Colorado Holdings LLC	270,426	$1.69M	0.0%	-69.9%	0.558%
8/14/2023	State of Wisconsin Investment Board	108,100	$0.68M	0.0%	+71.6%	0.223%
8/14/2023	State Street Corp	641,581	$4.02M	0.0%	-17.2%	1.324%
8/14/2023	Nuveen Asset Management LLC	192,384	$1.20M	0.0%	+118.4%	0.397%
8/11/2023	BlackRock Inc.	4,677,028	$29.28M	0.0%	+16.1%	10.216%
8/11/2023	Sectoral Asset Management Inc.	332,250	$2.08M	0.3%	+32.7%	0.726%
8/11/2023	State Board of Administration of Florida Retirement System	10,944	$69K	0.0%	N/A	0.024%
8/11/2023	The Manufacturers Life Insurance Company	16,935	$0.11M	0.0%	+15.1%	0.037%
8/11/2023	Hsbc Holdings PLC	39,056	$0.24M	0.0%	+39.5%	0.085%
8/11/2023	Geode Capital Management LLC	745,334	$4.67M	0.0%	+11.9%	1.628%
8/11/2023	JPMorgan Chase & Co.	4,075,504	$25.51M	0.0%	+1.8%	8.902%
8/11/2023	Northern Trust Corp	320,798	$2.01M	0.0%	+4.0%	0.701%
8/10/2023	Personal CFO Solutions LLC	350,342	$2.19M	0.4%	-36.3%	0.765%
8/10/2023	Charles Schwab Investment Management Inc.	259,842	$1.63M	0.0%	+2.5%	0.568%
8/10/2023	Citigroup Inc.	64,320	$0.40M	0.0%	+11.5%	0.141%
8/9/2023	Dimensional Fund Advisors LP	314,312	$1.97M	0.0%	-22.8%	0.687%
8/8/2023	Belvedere Trading LLC	24,411	$0.15M	0.0%	N/A	0.053%
8/7/2023	Principal Financial Group Inc.	926,735	$5.80M	0.0%	+1.0%	2.024%
8/7/2023	New York Life Investment Management LLC	86,401	$0.54M	0.0%	-7.5%	0.189%
8/4/2023	Simplex Trading LLC	10,692	$66K	0.0%	N/A	0.023%
8/3/2023	Los Angeles Capital Management LLC	62,530	$0.39M	0.0%	+24.9%	0.137%
8/3/2023	Barclays PLC	240,320	$1.50M	0.0%	-6.1%	0.496%
8/3/2023	Bank of New York Mellon Corp	124,738	$0.78M	0.0%	+1.8%	0.272%
8/2/2023	Bank of Montreal Can	698,184	$4.44M	0.0%	N/A	1.525%
7/24/2023	Vontobel Holding Ltd.	332,250	$2.08M	0.0%	+32.7%	0.726%
7/18/2023	Denali Advisors LLC	30,500	$0.19M	0.1%	N/A	0.067%
7/17/2023	Mesirow Financial Investment Management Inc.	34,748	$0.22M	0.9%	N/A	0.076%
5/18/2023	JPMorgan Chase & Co.	4,002,884	$19.09M	0.0%	-2.3%	8.744%
5/18/2023	New York State Common Retirement Fund	10,218	$49K	0.0%	-62.0%	0.022%
5/16/2023	Jane Street Group LLC	235,447	$1.12M	0.0%	+224.7%	0.514%
5/16/2023	State Street Corp	775,000	$3.70M	0.0%	-76.6%	1.693%
5/16/2023	Squarepoint Ops LLC	256,563	$1.22M	0.0%	+1,312.2%	0.560%
5/16/2023	Geode Capital Management LLC	666,111	$3.18M	0.0%	+2.5%	1.455%
5/16/2023	ArrowMark Colorado Holdings LLC	899,561	$4.29M	0.0%	-6.8%	1.965%
5/15/2023	Cubist Systematic Strategies LLC	84,517	$0.40M	0.0%	+5.5%	0.185%
5/15/2023	Two Sigma Advisers LP	54,900	$0.26M	0.0%	N/A	0.120%
5/15/2023	Two Sigma Investments LP	136,950	$0.65M	0.0%	+878.2%	0.299%
5/15/2023	Deutsche Bank AG	32,854	$0.16M	0.0%	+63.9%	0.072%
5/15/2023	Price T Rowe Associates Inc. MD	23,617	$0.11M	0.0%	+28.8%	0.052%
5/15/2023	RTW Investments LP	2,999,098	$14.31M	0.3%	-31.2%	6.552%
5/12/2023	BlackRock Inc.	4,030,169	$19.22M	0.0%	+16.8%	8.804%
5/12/2023	Sectoral Asset Management Inc.	250,469	$1.20M	0.2%	N/A	0.547%
5/12/2023	Bank of America Corp DE	931,698	$4.44M	0.0%	-8.2%	2.035%
5/12/2023	Nextech Invest Ltd.	521,284	$2.49M	1.0%	-62.4%	1.139%
5/12/2023	HRT Financial LP	292,652	$1.40M	0.0%	+88.6%	0.639%
5/12/2023	UBS Group AG	89,644	$0.43M	0.0%	-68.5%	0.196%
5/12/2023	Dimensional Fund Advisors LP	407,312	$1.94M	0.0%	-23.5%	0.890%
5/12/2023	Wellington Management Group LLP	870,054	$4.15M	0.0%	+5.5%	1.901%
5/11/2023	M&T Bank Corp	45,090	$0.22M	0.0%	+8.9%	0.098%
5/11/2023	Citigroup Inc.	57,703	$0.28M	0.0%	-50.3%	0.126%
5/10/2023	Swiss National Bank	44,400	$0.21M	0.0%	-7.9%	0.097%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	156,058	$0.74M	0.0%	+34.9%	0.341%
5/9/2023	Principal Financial Group Inc.	917,885	$4.38M	0.0%	+2.5%	2.005%
5/9/2023	Fishman Jay A Ltd. MI	25,000	$0.12M	0.0%	+25.0%	0.055%
5/9/2023	Y Intercept Hong Kong Ltd	33,272	$0.16M	0.0%	N/A	0.073%
5/8/2023	New York Life Investment Management LLC	93,363	$0.45M	0.0%	N/A	0.204%
5/8/2023	Federated Hermes Inc.	498,263	$2.38M	0.0%	+659.7%	1.088%
5/8/2023	Zurcher Kantonalbank Zurich Cantonalbank	6,443	$31K	0.0%	+218.6%	0.014%
5/4/2023	Barclays PLC	255,922	$1.22M	0.0%	+57.7%	0.559%
4/18/2023	Assenagon Asset Management S.A.	420,824	$2.01M	0.0%	-4.6%	0.919%
4/12/2023	Vontobel Holding Ltd.	250,469	$1.20M	0.0%	N/A	0.547%
2/16/2023	Point72 Middle East FZE	8,266	$72K	0.0%	N/A	0.018%

Data available starting January 2016

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects mutant p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also developing Wild-type p53 or other p53 mutations, including R273H, R273C, R175H, G245S, R248Q, and R282W, as well as other p53 hotspot mutations. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Cranbury, New Jersey.

Today's Range

Now: $2.31

$2.25

$2.36

50 Day Range

MA: $2.65

$1.23

$6.60

52 Week Range

Now: $2.31

$1.17

$10.22

Volume

248,000 shs

Average Volume

574,458 shs

Market Capitalization

$118.17 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.57

Who are the company insiders with the largest holdings of PMV Pharmaceuticals?: PMV Pharmaceuticals' top insider investors include:
Orbimed Advisors Llc (Major Shareholder)
Deepika Jalota (Insider)
Learn More about top insider investors at PMV Pharmaceuticals.
Who are the major institutional investors of PMV Pharmaceuticals?: PMV Pharmaceuticals' top institutional shareholders include:
JPMorgan Chase & Co. — 7.88%
Euclidean Capital LLC — 5.14%
RTW Investments LP — 4.64%
Alkeon Capital Management LLC — 4.59%
Principal Financial Group Inc. — 1.90%
Federated Hermes Inc. — 1.53%
Learn More about top institutional investors of PMV Pharmaceuticals stock.
Which major investors are selling PMV Pharmaceuticals stock?: Within the previous quarter, PMVP stock was sold by these institutional investors:
RTW Investments LP
Assenagon Asset Management S.A.
GSA Capital Partners LLP
Federated Hermes Inc.
Qube Research & Technologies Ltd
JPMorgan Chase & Co.
Vontobel Holding Ltd.
Sectoral Asset Management Inc.
Within the last year, company insiders that have sold PMV Pharmaceuticals company stock include:
Orbimed Advisors Llc (Major Shareholder)
Deepika Jalota (Insider)
Learn More investors selling PMV Pharmaceuticals stock.
Which major investors are buying PMV Pharmaceuticals stock?: In the previous quarter, PMVP stock was purchased by institutional investors including:
Alkeon Capital Management LLC
Citigroup Inc.
Citigroup Inc.
Barclays PLC
Euclidean Capital LLC
Schonfeld Strategic Advisors LLC
Trexquant Investment LP
UBS Group AG

All the trading advice you’ve ever received boils down to this

From DTI Trader | Ad

Drop everything and learn about the Income Calendar now.

PMVP Insider Trading

PMV Pharmaceuticals Insider Trading History Chart

PMV Pharmaceuticals Share Price & Price History

PMV Pharmaceuticals Insider Trading History

SEC Filings (Institutional Ownership Changes) for PMV Pharmaceuticals (NASDAQ:PMVP)

Institutional Buying and Selling by Quarter

PMV Pharmaceuticals Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of PMV Pharmaceuticals?

Who are the major institutional investors of PMV Pharmaceuticals?

Which major investors are selling PMV Pharmaceuticals stock?

Which major investors are buying PMV Pharmaceuticals stock?